ISO 25539-4:2021

Overview

ISO 25539-4:2021 - Cardiovascular implants - Endovascular devices - Part 4 - provides guidance on the application of ISO 17327-1:2018 specifically to coated endovascular devices. It clarifies which requirements and evaluations from the general implant-coating standard (ISO 17327-1) apply to coated vascular stents, endovascular prostheses, and vena cava filters, and how to integrate those requirements with the device-specific ISO series and related standards.

Key scope points:

• Addresses drug coatings (eluting and non‑eluting), non‑drug coatings (absorbable and non‑absorbable), and chemistry-related surface modifications (oxide, e.g., TiO2; non‑oxide, e.g., amorphous silicon carbide, diamond‑like carbon).
• Supplements ISO 25539-1, ISO 25539-2, ISO 25539-3, ISO 12417-1 and ISO/TS 17137.
• Excludes coated delivery systems and ancillary devices (e.g., guidewires) and does not cover viable tissue or non‑viable biologic coating materials. Device coverings are out of scope unless the covering itself is coated.

Key topics and requirements

• Tailored application of ISO 17327-1: Identifies which generic coating properties are relevant to endovascular implants and maps them to device‑specific standards.
• Device evaluation strategy: Testing and characterization are selected based on device design, intended use and potential failure modes (as described in ISO 25539‑1/2).
• Coating property focus: Includes coating integrity, drug content and release for drug-eluting coatings, degradability for absorbable coatings, chemical composition, and corrosion/coverage integrity for surface modifications.
• Evaluation approach: For endovascular devices, adhesion strength and abrasion resistance are typically assessed indirectly via simulated use, durability testing and particulate generation rather than explicit “load per unit area” adhesion tests.
• Not generally required: Porosity, pore size, surface wettability and surface texture are generally not applicable unless the device evaluation strategy identifies a need.
• Informative test matrices: The standard contains tables correlating applicable requirements and suggested (non-mandatory) test methods for each coating type.

Applications - who uses this standard

• Medical device manufacturers - design, characterization and verification of coated stents, prostheses and filters.
• R&D and quality teams - selection of relevant coating tests and demonstrating maintenance of coating integrity.
• Regulatory and conformity assessors / notified bodies - evaluating evidence in technical files and submissions.
• Test laboratories - aligning test programs with endovascular device–specific requirements.

Related standards

• ISO 17327-1:2018 (Implant coating - general requirements)
• ISO 25539-1:2017 (Endovascular prostheses)
• ISO 25539-2:2020 (Vascular stents)
• ISO 25539-3:2011 (Vena cava filters)
• ISO 12417-1:2015 (Vascular device‑drug combination products)
• ISO/TS 17137:2021 (Cardiovascular absorbable implants)

Keywords: ISO 25539-4:2021, coated endovascular devices, implant coatings, vascular stents, endovascular prostheses, vena cava filters, ISO 17327-1, drug coatings, surface modifications, device evaluation strategy.